Two-Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD (Q58971166)
scientific article published on 01 December 2007
Language:
(P31) (Q13442814)
(P50) (Q35705017)
(Q91720749)
(P304) 1832-1841
(P433) 12
(P478) 22
(P577) Saturday, December 1, 2007
(P1433) (Q15750941)
(P1476) "Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD" (language: en)
(P2093) E Michael Lewiecki
Paul D Miller
Michael A Bolognese
Yu Liu
Andrea Wang
Suresh Siddhanti
Lorraine A Fitzpatrick
AMG 162 Bone Loss Study Group
(P2860) (Q41753607)
(Q34912769)
other details
description scientific article published on 01 December 2007

External Links